WVE Wave Life Sciences Ltd.
Healthcare$6.38+0.00%ClosedMarket Cap: $1.23B
As of 2026-05-26
Institutional Ownership Summary
Investors Holding
237
13F Shares
182,748,128
Ownership %
108.9%
New Positions
71
Increased Positions
148
Closed Positions
44
Reduced Positions
49
ETF Exposure
| ETF Symbol | ETF Name | Shares Held | Weight % |
|---|---|---|---|
| Global X - Genomics & Biotechnology ETF | 56,445 | 1.48% | |
| 419,283 | 0.95% | ||
| Direxion Daily Pharmaceutical & Medical Bull 3X ETF | 11,798 | 0.61% | |
| Fidelity Disruptive Medicine ETF | 40,000 | 0.46% | |
| Roundhill Investments - GLP-1 & Weight Loss ETF | 32,778 | 0.43% | |
| Virtus Biotech Clinical Trials ETF | 16,465 | 0.33% | |
| Goldman Sachs Small Cap Equity ETF | 67,445 | 0.30% | |
| iShares U.S. Pharmaceuticals ETF | 404,066 | 0.28% | |
| 404,066 | 0.28% | ||
| 352,470 | 0.20% | ||
| iShares Micro-Cap ETF | 352,470 | 0.20% | |
| Nuveen ESG Small-Cap | 130,612 | 0.11% | |
| Invesco Nasdaq Biotechnology ETF | 11,071 | 0.10% | |
| iShares Biotechnology ETF | 1,176,186 | 0.10% | |
| 94,017 | 0.09% | ||
| iShares Russell 2000 Growth ETF | 1,010,836 | 0.06% | |
| 1,010,836 | 0.06% | ||
| 573,486 | 0.05% | ||
| Global X - Russell 2000 ETF | 53,245 | 0.05% | |
| T. Rowe Price Small-Mid Cap ETF | 121,058 | 0.05% |